Sign in
8-K

Current Report

MoonLake Immunotherapeutics Filed Acc 0001213900-26-063125

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading ea0292693-8k_moonlake.htm…